ARKG250117C15000
- 9.30
- 0.000.00%
ARK Genomic Revolution ETF Newsroom
ETFs Shine As S&P 500 Hits Record High: Top 5 ETFs With Best Gains From Last Week
Stargate Project's Healthcare Winners: AI-led Biotechs and Metagenomi
Tempus AI Shares Are Trading Lower, Possibly Pulling Back From Strength Earlier in the Week.
Schrodinger Analyst Ratings
Aiming for a 10-year extension! The AI pharmaceutical company invested by Altman is seeking to raise 1 billion dollars.
The biotechnology startup Retro Biosciences is conducting Series A financing to research projects that use AI technology to extend human lifespan. Previously, Altman had invested $0.18 billion in the seed round of financing for Retro Biosciences, and in this Series A financing, Altman will add further investment.
Natera Analyst Ratings
Cathie Wood Goes All in on Tempus AI, Boosting Holdings by Over 600K Shares in 2025
Trump's HHS Pick RFK Jr. to Face Key Senate Hearings Next Week
Guardant Health Presents Phase II NEO Trial Data On Guardant Reveal Tool For Organ Preservation In Node-Negative Rectal Cancer At The ASCO GI Symposium
Cathie Wood Sees Trump's Second Term Reviving IPO Market, Unlocking Opportunities In Biotech And AI Sectors
CRISPR Therapeutics Stock Pops Following Disclosure of RFK Jr. Investment
Schrodinger Shares Are Trading Higher Following Mention in a Report From Hunterbrook Capital.
Moderna Spikes as Oracle's Larry Ellison Touts AI-driven MRNA Vaccines
Watching Schrodinger; Hunterbrook Issues Report On Co Titled "Schrödinger: The Nvidia Biotech Partner Jensen Huang Told To 'Think Bigger'"
Guardant Health Analyst Ratings
Seagate Posts Upbeat Earnings, Joins Netflix, Travelers, Teledyne Technologies And Other Big Stocks Moving Higher On Wednesday
Natera Shares Are Trading Higher After the Company Announced It Will Reveal New Insights and Innovations for Tissue-free MRD at ASCO GI 2025
Tempus AI surged by 35% after being targeted by the "Congressional Stock God"! What other "AI + Medical" Stocks are worth paying attention to?
After CES 2025, Goldman Sachs released Research Reports highlighting several key themes and companies in the pharmaceutical and health Industry: Abbott Laboratories, Teladoc Health, and iRhythm Technologies are well positioned.
Cathie Wood's Ark Invest Buys Into Defense And Energy Stocks Amid Trump's Inaugural Policies
Google Parent-Owned Startup To Launch AI-Designed Drug Trials By Year-End, Partnering With Eli Lilly And Novartis To Tackle Major Diseases